
Health Check: Telix licks its wounds after FDA knocks back brain cancer diagnostic
Telix is in the dog house after a shock FDA knock-back, but will regroup and try again. Pic via Getty The FDA has told Telix to do more work on its imaging agent for rare brain cancers But the agency tells Dimerix it can use a surrogate endpoint for its …